Researchers assessed the effectiveness of a modified SUNTRAC to identify risk of skin cancer in solid organ transplant recipients.

Investigators presented initial results from the phase 3 RAMPART trial of adjuvant durvalumab monotherapy or combined with tremelimumab for resected primary renal cell carcinoma.

Increase seen in overall survival, especially among those with HER2+-positive cancers, with median increase of more than 10 months.

Oncology care gaps are more pronounced among rural populations, and in counties with higher levels of cancer mortality, health risks, and socioeconomic risks, researchers reported.

Thrombosis occurs in more than 1 in 10 adults receiving PEGylated asparaginase (Asp)–based therapy for acute lymphoblastic leukemia (ALL), with a 4-fold ...

Given that only about 1 in 4 eligible individuals currently receive housing assistance, a potential benefit of extending housing assistance may be earlier-stage diagnoses of these cancers,” ...

Exerkines, the molecular signals released through physical exertion, may be protective against radiation toxicities for patients with prostate cancer.

The approval for HR-SMM was based on data from the phase 3 AQUILA study, which evaluated Darzalex Faspro in adults aged 31 years and older with HR-SMM.

Disitamab vedotin plus toripalimab improved progression-free survival and overall survival when compared to chemotherapy.

A study on oncology care models demonstrates the potential of nurse practitioners to lead multidisciplinary oncologic care teams.

Consistently reaching guidelines at moderate levels over three decades associated with significant reduction in DSC risk.

Rates of overall survival, prostate cancer-specific death, and distant metastasis were similar in patients who received prophylactic whole pelvic radiotherapy compared to those who received ...